TY  - GEN
TY  - GEN
T1  - Novel Technologies for Vaccine Development
A2  - Lukashevich, Igor S.
A2  - Lukashevich, Igor S.
A2  - Shirwan, Haval.
A2  - Shirwan, Haval.
LA  - English
PP  - Vienna
PB  - Springer Vienna : Imprint: Springer
YR  - 2014
ED  - 1st ed. 2014.
UL  - http://discoverylib.upm.edu.my/discovery/Record/978-3-7091-1818-4
AB  - This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new generation of vector-based vaccines. Furthermore, specific topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines are presented. Given its scope, the book is a “must read” for all those involved in vaccine development, both in academia and industrial vaccine development.
OP  - 386
CN  - RM281
SN  - 9783709118184
KW  - Vaccines.
KW  - Pharmaceutical technology.
KW  - Immunology.
KW  - Vaccine.
KW  - Pharmaceutical Sciences/Technology.
ER  -